ProMIS Neurosciences Inc. (PMN)
↓ Download CSV| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Operating Income | -$40.17M | -$16.83M | -$14.26M | -$23.38M | -$8.29M | — |
| Net Income | -$39.72M | $2.78M | -$13.21M | -$18.06M | -$9.79M | — |
| EPS (Diluted) | $-22.61 | $2.63 | $-1.07 | $-2.41 | $-1.69 | — |
| Total Assets | $9.18M | $18.91M | $13.62M | $6.92M | $17.75M | — |
| Total Liabilities | $10.44M | $2.42M | $9.87M | $8.27M | $12.09M | — |
| Shareholders' Equity | -$1.26M | $16.49M | $3.75M | -$1.35M | $5.66M | -$796.7K |
| Cash & Equivalents | $6.12M | $13.29M | $12.60M | $5.88M | $16.94M | — |
| Operating Cash Flow | -$28.12M | -$27.18M | -$10.84M | -$17.03M | -$9.31M | — |
| Capital Expenditures | — | — | — | $2.0K | $6.0K | — |
| Shares Outstanding | 2.15M | 1.31M | 18.89M | 8.58M | 7.20M | — |